search
Back to results

Perform Necrotic Cavity Lavage or Not After Debridement of Infected Pancreatic Necrosis (NCLAD)

Primary Purpose

Pancreatitis,Acute Necrotizing, Pancreas Necrosis

Status
Unknown status
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
necrotic cavity lavage
Sponsored by
Xuanwu Hospital, Beijing
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pancreatitis,Acute Necrotizing focused on measuring acute pancreatitis, infected pancreatic necrosis, laparoscope-assisted debridement, necrotic cavity lavage

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. diagnosis of IPN
  2. onset time of >4 weeks
  3. performance of LAD for IPN
  4. provision of written informed consent

Exclusion Criteria:

  1. the highest temperature in 24 hours of ≥38.5ºC
  2. new organ failure occurring within 24 hours after the operation
  3. digestive tract fistula, biliary tract or digestive tract obstruction, or bleeding occurring within 24 hours after the operation
  4. abdominal pressure of ≥10 mmHg within 24 hours after the operation
  5. traumatic pancreatitis or a pancreatic fistula-related infection after the pancreatic operation

Sites / Locations

  • Xuanwu hospital Capital Medical UniversityRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

necrotic cavity lavage

non-necrotic cavity lavage

Arm Description

This arm was performed necrotic cavity lavage after debridement

This arm was not performed necrotic cavity lavage after debridement

Outcomes

Primary Outcome Measures

sum rate of mortality and major complications
number of deaths and major complications (new organ failure or intraperitoneal hemorrhage/gastrointestinal fistula requiring surgical treatment)/total enrollment

Secondary Outcome Measures

physiological parameter
body temperature in degree centigrade
physiological parameter
abdominal pressure in mmHg
assay index
white blood cell in 109/L
assay index
c-reactive protein in mg/L
assay index
procalcitonin in ng/ml
assay index
interleukin-6 in pg/ml
incidence of peritonitis and lower extremity deep vein thrombosis
postoperative complication
Acute Physiology and Chronic Health Evaluation (range:0-71)
The score shows the severity of the patients and higher scores mean a worse outcome
Total stay in hospital
The time for the patient staying in hospital measured in days
Length of stay in Intensive Care Unit
The time for the patient staying in Intensive Care Unit measured in days

Full Information

First Posted
February 12, 2020
Last Updated
June 16, 2020
Sponsor
Xuanwu Hospital, Beijing
search

1. Study Identification

Unique Protocol Identification Number
NCT04275466
Brief Title
Perform Necrotic Cavity Lavage or Not After Debridement of Infected Pancreatic Necrosis
Acronym
NCLAD
Official Title
A Randomized Controlled Trials on the Effect of Necrotic Cavity Lavage After Laparoscope-assisted Debridement for Patients With Infected Pancreatic Necrosis
Study Type
Interventional

2. Study Status

Record Verification Date
February 2020
Overall Recruitment Status
Unknown status
Study Start Date
June 12, 2020 (Actual)
Primary Completion Date
June 12, 2021 (Anticipated)
Study Completion Date
October 12, 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Xuanwu Hospital, Beijing

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The infected pancreatic necrosis (IPN) should be treated by debridement and drainage. In recent years, the results of clinical research show that minimally invasive debridement such as video-assisted (laparoscope, nephroscope, endoscopy, etc.) and total laparoscopic debridement can significantly improve the prognosis of IPN patients. After a long period of clinical practice, laparoscope-assisted debridement was selected as the main surgical method in our center. In many large-scale clinical studies, patients after surgery underwent necrotic cavity lavage (such as small omental sac lavage, retroperitoneal space lavage, peripancreatic lavage, etc.), but its necessity and clinical significance were not clearly stated in the guidelines. At present, the clinical research mainly focuses on the improvement of minimally invasive debridement, and less on the necessity of lavage. In the past, necrotic cavity lavage was performed in IPN patients, but long-term clinical observation showed that lavage may lead to spread of infection and increase the incidence of lower extremity venous thrombosis which is not accorded with ERAS(Enhanced Recovery After Surgery). Therefore, since 2012, our center has stopped necrotic cavity lavage for IPN patients after debridement. We retrospectively analyzed the therapeutic effect from February 2014 to August 2017 and found that even without necrotic cavity lavage, better therapeutic effect could be achieved. Meanwhile it can simplify the operation process and avoid infection spread. This treatment method provides a new idea. However, it is a retrospective study not a randomized controlled trials(RCT) which is low effectiveness of proof. Therefore, we design this RCT to verify the necessity of necrotic cavity lavage after laparoscope-assisted debridement for patients with infected pancreatic necrosis.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pancreatitis,Acute Necrotizing, Pancreas Necrosis
Keywords
acute pancreatitis, infected pancreatic necrosis, laparoscope-assisted debridement, necrotic cavity lavage

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
112 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
necrotic cavity lavage
Arm Type
Experimental
Arm Description
This arm was performed necrotic cavity lavage after debridement
Arm Title
non-necrotic cavity lavage
Arm Type
No Intervention
Arm Description
This arm was not performed necrotic cavity lavage after debridement
Intervention Type
Procedure
Intervention Name(s)
necrotic cavity lavage
Intervention Description
At least two 30- to 36-Fr drainage tubes will be placed into each necrotic cavity. One of these drainage tubes will be used as the lavage tube; the other tube is designed for drainage. Lavage will begin on the first day after debridement, and the relevant indices will be evaluated every 7 days to decide whether to continue the lavage. 1200 mL of normal saline will be lavaged into each necrotic cavity every day at a speed of 200 mL/h for 3 hours each time and for a total of two times. The start times of lavage will be 08:00 and 20:00. The lavage and drainage volumes of the first hour and second hour of each lavage session will be calculated. The lavage of the next hour will be stopped if the lavage volume minus the drainage volume is >100 mL. Lavage will be suspended if abdominal pain and distention occur, the maximum body temperature is >38.5ºC, or the abdominal pressure is ≥15 mmHg during the lavage procedure.
Primary Outcome Measure Information:
Title
sum rate of mortality and major complications
Description
number of deaths and major complications (new organ failure or intraperitoneal hemorrhage/gastrointestinal fistula requiring surgical treatment)/total enrollment
Time Frame
1 year
Secondary Outcome Measure Information:
Title
physiological parameter
Description
body temperature in degree centigrade
Time Frame
through study completion, an average of 2 months
Title
physiological parameter
Description
abdominal pressure in mmHg
Time Frame
through study completion, an average of 2 months
Title
assay index
Description
white blood cell in 109/L
Time Frame
through study completion, an average of 2 months
Title
assay index
Description
c-reactive protein in mg/L
Time Frame
through study completion, an average of 2 months
Title
assay index
Description
procalcitonin in ng/ml
Time Frame
through study completion, an average of 2 months
Title
assay index
Description
interleukin-6 in pg/ml
Time Frame
through study completion, an average of 2 months
Title
incidence of peritonitis and lower extremity deep vein thrombosis
Description
postoperative complication
Time Frame
through study completion, an average of 2 months
Title
Acute Physiology and Chronic Health Evaluation (range:0-71)
Description
The score shows the severity of the patients and higher scores mean a worse outcome
Time Frame
through study completion, an average of 2 months
Title
Total stay in hospital
Description
The time for the patient staying in hospital measured in days
Time Frame
through study completion, an average of 2 months
Title
Length of stay in Intensive Care Unit
Description
The time for the patient staying in Intensive Care Unit measured in days
Time Frame
through study completion, an average of 2 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: diagnosis of IPN onset time of >4 weeks performance of LAD for IPN provision of written informed consent Exclusion Criteria: the highest temperature in 24 hours of ≥38.5ºC new organ failure occurring within 24 hours after the operation digestive tract fistula, biliary tract or digestive tract obstruction, or bleeding occurring within 24 hours after the operation abdominal pressure of ≥10 mmHg within 24 hours after the operation traumatic pancreatitis or a pancreatic fistula-related infection after the pancreatic operation
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Chongchong Gao, MD
Phone
+86-15110182365
Email
scientificsalon@sina.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Fei Li, MD
Organizational Affiliation
Xuanwu Hospital, Beijing
Official's Role
Principal Investigator
Facility Information:
Facility Name
Xuanwu hospital Capital Medical University
City
Beijing
State/Province
Beijing
ZIP/Postal Code
100053
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Xinya Wang
Phone
+86-18610240907
Email
346683615@qq.com

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Perform Necrotic Cavity Lavage or Not After Debridement of Infected Pancreatic Necrosis

We'll reach out to this number within 24 hrs